Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Primary Results From the Multicenter, Randomized, Phase 2 DESTINY-CRC02 Study - T-DXd in Patients With HER2+ mCRC"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Kanwal Raghav
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Kanwal Raghav
67 views
July 11, 2023
Comments 0
Login to view comments.
Click here to Login
GI